adipocyte ͉ Cide ͉ diabetes ͉ fat droplet ͉ fat metabolism
T ype 2 diabetes mellitus and obesity are associated disorders and are increasing in incidence worldwide (1) . It is now evident that adipose tissue plays a central role in regulating whole-body metabolism and glucose homeostasis in addition to its well known function to store and mobilize triglyceride (2) . High concentrations of circulating fatty acids and triglyceride, observed in both obesity and lipodystrophy, are thought to cause muscle insulin resistance and decreased glucose tolerance. This hypothesis is supported by experiments showing that elevation of circulating fatty acids by infusion of lipid into humans impairs insulin sensitivity in skeletal muscle (3) (4) (5) . Several mechanisms may account for the ability of abnormally high levels of fatty acids in muscle to inhibit insulin signaling, including the activation of protein kinases such as PKC, IKK␤, and JNK that are negative regulators of elements of the insulin signaling pathway, notably IRS proteins (6) (7) (8) . Adipocytes can hypothetically protect muscle and liver from these deleterious effects of fatty acids by their large capacity to esterify them into triglyceride and to sequester large amounts of the triglyceride within lipid droplets. Evidence for this hypothesis is provided by the demonstrated reversal of insulin resistance by transplantation of adipose tissue into genetically manipulated ''fatless'' mice, which are devoid of adipocytes (9, 10) .
The efficiency and capacity of adipocytes to esterify fatty acids into triglyceride and protect triglyceride stores within the cells is controlled within large lipid droplets surrounded by a phospholipid layer and lipid droplet proteins (11, 12) . These proteins include the ''PAT'' domain-containing proteins perilipin TIP47 and ADRP, which are targeted to lipid droplets and regulate the size and biogenesis of these organelles (12) . Recently we identified Cidec/ FSP27 as a novel lipid droplet-associated protein in adipocytes and showed that Cidec/FSP27 negatively regulates lipolysis and promotes triglyceride accumulation (13, 14) . Cidec/FSP27 is a CIDE-N domain-containing protein and belongs to CIDE family of proteins. The CIDE family of proteins has three members in mice (Cidea, Cideb, and FSP27) and humans (CIDEA, CIDEB, and CIDEC, similar to FSP27) (15) . They have a common N-terminal CIDE-N domain and a C-terminal CIDE-C domain. A significant homology has been found between the CIDE-N domain of CIDE proteins and the regulatory domains of the apoptotic DNA fragmentation factors, DFF40 (caspase-activated nuclease) and DFF45 (DFF40 inhibitor) (16) (17) (18) (19) . Thus, it was surprising to find that Cidec/FSP27 functions as a lipid droplet-associated protein in mouse adipocytes to regulate fat deposition (13, 14) .
The Cide domain-containing protein Cidea is also known to be highly expressed in adipose tissue. In mice it is largely restricted to brown adipose tissue (BAT) (18) whereas in humans Cidea is highly expressed in WAT (20, 21) . In previous studies, Cidea was proposed to be a mitochondrial protein that negatively regulates the activity of the BAT uncoupling protein UCP1 (18, 19) , consistent with its high expression in mouse BAT. However, based on the sequence similarity between Cidea and Cidec/FSP27 and on our findings revealing Cidec/FSP27 to be a lipid droplet-associated protein, a similar function for Cidea seemed likely. In the present studies we discovered that Cidea indeed localizes to lipid droplets and regulates triglyceride deposition in adipocytes as well as other cell types. Remarkably, we found that both Cidea and Cidec/FSP27 expression in WAT of obese human subjects also correlates positively with whole-body insulin sensitivity, as does the known lipid droplet protein perilipin. Taken together, these results are consistent with the hypothesis that Cide domain-containing proteins play an important role in sequestration of triglyceride within human adipocytes, promoting whole-body insulin sensitivity.
Results and Discussion
Identification of Cidea as a Lipid Droplet Protein. In considering that Cidea may share functions with the lipid droplet protein Cidec/ FSP27, we noted that Cidea displays almost 61% sequence identity with Cidec/FSP27 [supporting information (SI) Figs. S1-S3]. We then compared amino acid sequences within the Cidea and Cidec/ FSP27 proteins with those in the prototypic lipid droplet protein perilipin. This analysis of sequences within the Cidea and Cidec/ FSP27 proteins revealed four regions of low but significant similarity to perilipin (Fig. 1) . These regions included a short N-terminal sequence (I) with shared similarity to adipophilin, a segment (II) with similarity to a region of perilipin thought to shield lipid droplets from lipases, and two regions (III and IV) thought to function in the targeting and binding of perilipin to lipid droplets (22) . Interestingly, there is no similarity between sequences in the PAT domain of perilipin, thought to be a signature structure for lipid droplet proteins, and sequences within the Cide proteins (data not shown). Fig. 2 confirms that the sequence similarities between the Cidea and perilipin reflect functional redundancies between these proteins. Ectopic expression of Cidea protein fused to GFP in 3T3-L1 adipocytes reveals its striking localization surrounding lipid droplets stained with oil red (Fig. 2a) . The expressed Cidea-GFP protein localized around lipid droplets but not with mitochondria, as detected by MitoTracker dye ( Fig. 2b ; also see Fig. S4 ). These data are reminiscent of the first described endogenous lipid dropletassociated protein, perilipin (23, 24) . Cidea is highly expressed in BAT but not WAT in the mouse. We therefore used human cultured adipocytes from WAT to assess its intracellular disposition (Fig. 2c) . Endogenous Cidea protein was found concentrated around lipid droplets and colocalized with endogenous perilipin (Fig. 2c) . Some punctate cytoplasmic staining was also observed in these experiments and requires further analysis. A previous report suggested that Cidea partially colocalizes with mitochondria in COS cells (18) and with mitochondrial UCP1 protein in BAT, but careful examination of expressed Cidea-GFP in COS cells in the present study showed little or no colocalization with mitochondria (Figs. S5 and S6). These studies cannot exclude the possibility that small amounts of Cidea may be associated with mitochondria but are not detected by these methods.
To further verify that Cidea is primarily localized around lipid droplets, we adopted an RNAi-based analysis in cultured brown adipocytes. These cells have low expression of FSP27 protein as compared with 3T3-L1 adipocytes (Fig. 3d) . Immunofluorescence using Cidea monoclonal antibody showed Cidea localization around lipid droplets in these cells transfected with scrambled siRNA (Fig. 3a) . Some droplets did not show Cidea staining, and some cytosolic punctuate staining was observed, which requires further analysis. To eliminate cross-reactivity of the antibody with FSP27 in these studies, we depleted FSP27 by 90% using RNAi. This had no effect on Cidea antibody staining around lipid droplets ( Fig. 3 b and d) . Importantly, depletion of Cidea itself with siRNA in these cells abolished the antibody staining around the lipid droplets, while some cytosolic punctuates were observed. This punctuate staining was partially due to nonspecific binding of the secondary antibody alone. 
Varying Expression Levels of Cidea Modulate Lipid Droplet Size and
Basal Lipolysis. Cidea and Cidec/FSP27 mRNA dramatically increased by Ͼ3-fold and 50-fold, respectively (Table S1 ), as mouse adipocytes acquire lipid storage capacity during differentiation. FSP27-GFP expression even in nonadipose cells leads to lipid accumulation (16) . We therefore tested the effect of increasing Cidea-GFP levels in 3T3-L1 preadipocytes on lipid accumulation in lipid droplets. These experiments revealed that preadipocytes expressing Cidea-GFP (Fig. 4a and Fig. S7 ) display lipid droplets of increased size as compared with neighboring untransfected cells. A similar result was obtained when Cidea-GFP (Fig. 4b and Fig. S7 ) expression in COS cells was examined-greatly increased lipid droplets. These results indicate that Cidea associates with lipid droplets and functions to strongly promote triglyceride accumulation even in cell types that do not normally store large amounts of neutral lipid. Morphometric analysis of oil red-stained lipid droplets in cells transfected with Cidea-GFP showed significantly higher volume than in untransfected cells or cells transfected with GFP vector alone (Fig. 4c and Figs. S7 and S8 ). These data reveal that Cidea (Fig. 4) and Cidec/FSP27 (13) function similarly in facilitating lipid droplet enlargement. Furthermore, in these nonadipose cells we observed that most of the Cidea was not directly associated with lipid droplets. This could be due to a requirement for other differentiation-dependent proteins to facilitate Cidea localization to lipid droplets.
Perilipin has little or no effect on the triacyglycerol synthetic pathway but inhibits triglyceride hydrolysis in adipocytes (25, 26) .
As shown in Table S2 , previous studies have also shown that depleting Cidea in human preadipocytes increases lipolysis. Nordstrom et al. (20) have shown that CIDEA mRNA expression is 50% lower in s.c. WAT of obese human subjects compared with lean subjects, and this correlates with a 2-fold increase in basal lipolysis. Moreover, 2-4 years after bariatric surgery and weight reduction, obese subjects displayed a doubling of CIDEA mRNA expression and a 40% reduced lipolytic rate in s.c. WAT (Table S2) . Furthermore, TNF-␣ treatment of differentiated primary human fat cells has been shown to increase lipolysis in proportion to the reduced CIDEA mRNA levels (Table S2) . Increased lipolysis was also observed in BAT from Cidea-null mice (18) . In our own recent studies, increased glycerol release in response to RNAi-mediated depletion of Cidec/FSP27 in 3T3-L1 adipocytes was observed (13) . These previously published studies, in combination with the data presented here, indicate that the physical localization of Cidea and Cidec/FSP27 with lipid droplets is associated with shielding triglycerides from hydrolysis by lipases.
Peroxisome proliferator-activated receptor ␥ (PPAR␥) is a major regulator of adipogenesis, and its expression during the differentiation program in adipose tissue is followed by accumulation of triglycerides within adipocytes (27) (28) (29) . We therefore studied the effect of PPAR␥ depletion by RNAi on Cidea and Cidec/FSP27 expression in adipocytes to determine whether these proteins are under the control of this transcription factor. As shown in Fig. 4d , Ϸ90% depletion of PPAR␥ mRNA in 3T3-L1 adipocytes leads to Ͼ90% depletion of Cidea and Cidec/FSP27 mRNA expression. Similar results of PPAR␥ depletion on Cidea mRNA were obtained in mouse brown adipocytes (Fig. 4e) . These results suggest that Cidea and Cidec/FSP27 expression in adipocytes is mediated directly or indirectly by PPAR␥. Furthermore, Cidea is undetectable in mouse liver but is highly expressed under conditions where PPAR␥ expression is increased, consistent with Cidea being a target gene for PPAR␥ (30, 31) . A recent study has indeed revealed that the mouse Cidea gene promoter has a putative peroxisome proliferator response element where the transcription factors PPAR␣ and PPAR␥ could bind and control Cidea gene transcription in the liver (31).
Cidea and Cidec/FSP27 mRNA Levels Are Up-Regulated Under Physiological Conditions That Enhance Triacylglycerol Deposition in Mice. A puzzling aspect of Cide domain-containing protein biology relates to the differential expression of the Cide proteins in mouse adipose tissues versus human adipose tissue. Whereas Cidec/FSP27 is highly expressed in both mouse BAT and WAT as well as human WAT, Cidea is highly expressed in mouse BAT and human WAT, but not mouse WAT (18, 20, 21) . This expression profile for endogenous Cidea is confirmed in our immunoblot studies using anti-Cidea antibody, as shown in Fig. 5a , where low Cidea expression is observed in mouse WAT compared with BAT or compared with human omental or s.c. WAT. The appearance of two bands for Cidea in mouse adipose tissues requires further analysis. We reasoned that if Cidea plays a major role in fat storage in mouse WAT, then its expression must be highly up-regulated under conditions of increased triglyceride deposition. We therefore determined Cidea mRNA levels under various physiological conditions, as shown in Fig. 5 b-e. Dramatic 6-to 10-fold increases in Cidea expression were observed in adipocytes under four different conditions known to be associated with increased triglyceride stores-treatment of ob/ob obese mice with rosiglitazone for 2 weeks, treatment of normal wild-type mice with rosiglitazone for 2 weeks, treatment of fully differentiated 3T3-L1 adipocytes with rosiglitazone for 24 h, and feeding of wild-type mice with a high-fat diet (Fig. 5b) .
We confirmed that the levels of Cidea and Cidec/FSP27 expression in mouse adipose tissue correlate with conditions of increased triglyceride deposition by measuring the rates of 14 C-glucose conversion to triglyceride glycerol in adipose tissue from 4-week-old lean ob/ob mice compared with 26-week-old obese ob/ob mice or compared with the latter mice treated with rosiglitazone for 14 days. As shown in Fig. 5c , net triglyceride synthesis was decreased in 26-week-old obese ob/ob mice compared with 4-week-old lean ob/ob mice or with obese (26-week-old ob/ob) mice treated with rosiglitazone. Similarly, Cidea and Cidec/FSP27 expression was decreased during the progression of obesity from 4 weeks to 26 weeks and restored by rosiglitazone treatment of the obese mice ( Fig. 5 d and e) . These data are consistent with the concept that Cidea and Cidec/FSP27 expression is under the control of PPAR␥, which also plummets during the progression of obesity in the ob/ob mouse model, but is activated by rosiglitazone. We confirmed that Cidea and Cidec/FSP27 expression depends on PPAR␥ levels in 3T3-L1 adipocytes by siRNA-mediated silencing of PPAR␥, which markedly reduced mRNA levels of both proteins in these cells (Fig.  4 d and e) . Interestingly, obesity in the ob/ob mice also caused dramatic decreases in the expression of other lipid droplet proteins in WAT, but, of the known lipid droplet proteins, Cidea was most responsive to the effects of rosiglitazone treatment (Fig. 5 c and d ; also see Table S1 ).
Cidea and Cidec/FSP27 Expression Correlates Positively with Insulin
Sensitivity in Obese Human Subjects Matched for BMI. It is thought that triglyceride storage in adipocytes plays an important role in sequestering triglycerides and fatty acids away from the circulation and peripheral tissues, thus enhancing insulin sensitivity in liver and muscle (10, 32) . If Cidea and Cidec/FSP27 function to decrease lipolysis and enhance triglyceride deposition in human WAT, it may play a role in enhancing whole-body insulin sensitivity. Nordstrom et al. (20) indeed reported negative correlations between Cidea expression in omental adipose tissue and both basal lipolysis and apparent insulin sensitivity (HOMA index) in a cohort of 186 lean and obese patients (also see Table S2 ). To further refine an analysis of the relationship between Cidea expression and insulin sensitivity, we assessed Cidea mRNA levels in s.c. and omental adipose samples from obese human subjects with similar high BMI values but different levels of insulin sensitivity (Fig. 6a) .
In preliminary studies (33) it was observed that, in a population of 138 such obese subjects with high BMI, approximately half of the nondiabetic subjects exhibited apparent high insulin sensitivity (low HOMA-IR index) and approximately half exhibited the expected insulin resistance (high HOMA-IR index). Furthermore, insulin resistance measured by HOMA-IR index was not correlated with BMI values in this cohort of very obese patients. We thus segregated adipose samples from such obese patients based on high or low HOMA-IR index values, reflecting relative insulin sensitivity or insulin resistance (Fig. 6a) . RT-PCR analysis revealed a highly significant 6-fold increase in Cidea expression in both omental and s.c. adipose tissue in the group of patients with low HOMA index (high insulin sensitivity) (Fig. 6 a and b) , and this was also seen in omental adipose tissue from full genome microarray data (Table  S3) . Perilipin was also elevated significantly in omental and s.c. adipose tissue from the low HOMA group, although less dramatically, whereas Cidec/FSP27 was elevated significantly in omental adipose tissue from this group. Taken together, these data show a strong negative correlation between expression levels of the lipid droplet proteins Cidea/Cidec/perilipin and an index of insulin resistance (HOMA) in obese patients matched for BMI. A previous study also showed that expression of Cidea in adipose tissue correlated inversely with whole-body insulin resistance in lean versus obese subjects (20) (Table S2 ). Here we extended these findings by showing that Cidea expression levels in human adipose tissue correlate with insulin sensitivity even when subjects are matched for BMI (Fig. 6) . The data we present in this paper also provide a hypothetical mechanistic rationale for these results: Cidea enhances storage of triglyceride in lipid droplets of adipose tissues, decreasing fatty acid levels in the circulation, thereby protecting muscle and liver from high fatty acid levels that impair insulin sensitivity. Thus, up-regulation of Cidea, Cidec/FSP27, and perilipin expression by rosiglitazone may be associated with fatsequestration and insulin-sensitizing effects of the drug in humans. Indeed, a recent study has reported an increased perilipin expres- sion in s.c. fat of rosiglitazone-treated fatty rats (34), consistent with this hypothesis and our data in mice (Fig. 5) . Failure to efficiently sequester lipid into the lipid storage droplets of adipocytes has been emphasized as a major contributor to the pathogenesis of insulin resistance (35) . The exact extent to which the capacity for triglyceride deposition in adipose tissue contributes to insulin sensitivity in obese patients will be important to rigorously determine in future studies.
Our results emphasize that Cidea, previously known to be a BAT protein in mice, is highly abundant in human WAT (20) (Fig. 5a) . The marked effect of Cidea to promote especially large lipid droplets when expressed in cells (Fig. 4) thus indicates a particularly important role for this protein in fat storage in human WAT. The potential failure to optimally store fat in adipose tissue in obesity may be exacerbated by the recruitment of macrophages into adipose tissue (36, 37) and the release of cytokines such as TNF␣ (38) , known to down-regulate PPAR␥ and therefore decrease triglyceride synthesis. It is thus noteworthy that high Cidea expression also appears to down-regulate TNF␣ expression in human adipose tissue, which may be related to its effect to decrease lipolysis (20, 39) . It has also been reported that a V115F polymorphism in human Cidea is associated with obesity in two Swedish samples of 981 women and 582 men (40) . Thus, it is likely that Cidea plays a central role in controlling metabolic flux in human adipose tissues through its regulation of fat storage in lipid droplets. Methods siRNA. siRNA was purchased from Dharmacon. Individual siRNA sequences include the following: scrambled, 5Ј-CAGUCGCGUUUGCGACUGG-3Ј; FSP27, 5Ј-CAACUAAGAAGAUCGAUGUUU-3Ј; perilipin, 5Ј-GCAGAACACUCUCCG-GAACUU-3Ј; Cidea, 5Ј-GGACACCGGGUAGUAAGUA3Ј.
Cell Culture and siRNA Transfection in 3T3-L1 Adipocytes. 3T3-L1 fibroblasts were cultured, and adipocytes were transfected with siRNA duplexes as described previously (41) (42) (43) .
Confocal Microscopy. Images were taken on a Zeiss Axiophot microscope equipped with a Hamamatsu digital camera and processed by using Metamorph imaging software, version 6.1 (Universal Imaging).
Statistical Analysis. Quantitative data are represented as mean Ϯ SEM. For statistical analysis the differences between groups were examined with Student's paired t test, and P Ͻ 0.05 was considered statistically significant.
Materials and the remaining methods on cells, transfection, constructs, RNAi, RNA isolation, RT-PCR, oil red staining, and immunofluorescence can be found in SI Materials and Methods.
